Risa Michelle Hoffman MD
HIV/AIDS Medicine
Associate Professor, Medicine, University of California Los Angeles David Geffen School of Medicine
Join to view full profile
10833 LeConte Avenue, 37-121 CHSLos Angeles, CA 90095
Phone+1 310-825-7225
Fax+1 310-825-7225
Dr. Hoffman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2005 - 2008
Mass General Brigham/Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2000 - 2005
David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
CA State Medical License 2003 - 2027
MA State Medical License 2003 - 2006
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV Start of enrollment: 2017 May 31
Publications & Presentations
PubMed
- Characteristics of new and re-initiating antiretroviral therapy clients in Malawi: implications for client counseling in resource-constrained settings.Marguerite Thorp, Kelvin Balakasi, Isabella Robson, Colbert Lemani, Sam Phiri
Global Health Action. 2026-12-01 - Hypertension in a Randomized Trial of Dolutegravir- Versus Efavirenz-Based Antiretroviral Therapy in Pregnant and Postpartum Women with HIV.Risa Hoffman, Sean Brummel, Mauricio Pinilla, Grace Malonga, Lameck Chinula
Clinical Infectious Diseases. 2026-09-02 - Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis.Risa Hoffman, Maya Watanabe, Esteban Martínez, Markella V Zanni, Anton Pozniak
Open Forum Infectious Diseases. 2026-09-01
Journal Articles
- Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral TherapyMurli U Purswani, Judith S Currier, Karin L Klingman, Risa M Hoffman, Clinical Infectious Diseases
Press Mentions
Three Steps to Speedier HIV Med Approvals for Pregnant PeopleJune 10th, 2021
Benefits Outweigh Risks of Dolutegravir for Women of Childbearing Age Living with HIV, Study ShowsApril 3rd, 2019
Avoiding Dolutegravir in Young Women with HIV: Time for a Rethink?April 1st, 2019
Grant Support
- Kupewa: Optimizing implementation strategies for cervical cancer preventionNEW YORK UNIVERSITY2024–2029
- Addressing Evolving Infectious ThreatsUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: